Pranavkumar Dalal, MD
Nephrology · Kansas City, MONPI 1083811293
Payments from drug & device makers
Across 35 payments — averaging $115.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$4K
- Eurofins Viracor, LLC$77
- Takeda Pharmaceuticals U.S.A., Inc.$65
- Mallinckrodt Enterprises LLC$57
- E.r. Squibb & Sons, L.L.C.$39
- Veloxis Pharmaceuticals, Inc.$33
- plus $120 from 7 others
What the payments were for
- Speaking & faculty fees$3,40084%
- Food & beverage$51313%
- Education$1163%
- Entertainment$261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 15 | $3,663 |
| Eurofins Viracor, LLC | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Mallinckrodt Enterprises LLC | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Veloxis Pharmaceuticals, Inc. | 1 | $33 |
| Teleflex LLC | 1 | $26 |
| Merck | 1 | $19 |
| Amgen | 1 | $18 |
| Medtronic | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 2 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTHAR$3,400
How this compares
$4,055 in reported general payments places this provider in the 75th percentile of 253 nephrology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 86 | $6,768 |
| Cinacalcet Hcl | 12 | $4,818 |
| Tacrolimus | 15 | $2,566 |
| Dapsone | 16 | $723 |
| Prednisone | 167 | $643 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 89 | $508 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $462 |
| Nifedipine ErNifedipine | 18 | $437 |
| Potassium Chloride | 15 | $281 |
| Carvedilol | 60 | $248 |
| Famotidine | 51 | $227 |
| Amlodipine Besylate | 81 | $191 |
| Hydralazine Hcl | 32 | $188 |
| Chlorthalidone | 15 | $155 |
| Torsemide | 16 | $144 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Kansas City
- Ahmed AwadKansas City$12.4M
- Kelly AlfordKansas City$58K
- Tarek DarwishKansas City$52K
- Archana GoelKansas City$49K
- Richard CaplingKansas City$31K
- Thomas WiegmannKansas City$25K
- Jignesh ShahKansas City$7K
- Adnan KhanKansas City$7K
- Robert GolderKansas City$5K
- Benjamin HumphreysSaint Louis$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.